BioLife Solutions Inc (BLFS)

Debt-to-equity ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Long-term debt	US$ in thousands	18,311	23,793	6,353	655	—
Total stockholders’ equity	US$ in thousands	337,663	364,188	478,047	204,429	43,321
Debt-to-equity ratio		0.05	0.07	0.01	0.00	0.00

December 31, 2023 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $18,311K ÷ $337,663K
= 0.05

BioLife Solutions Inc's debt-to-equity ratio has exhibited an increasing trend over the past five years, starting at 0.00 in 2019 and reaching 0.05 in 2023. This indicates that the company has been gradually taking on more debt relative to its equity during this period.

The sharp increase from 0.00 in 2019 to 0.01 in 2021 suggests a significant change in the company's capital structure, possibly due to funding requirements for expansion or other strategic initiatives. The subsequent rise to 0.07 in 2022 and then a slight decrease to 0.05 in 2023 indicate fluctuations in the company's debt and equity levels relative to each other.

Overall, a debt-to-equity ratio of 0.05 in 2023 implies that BioLife Solutions Inc is utilizing a moderate amount of debt to finance its operations compared to its equity. It is essential for investors and stakeholders to monitor this ratio to assess the company's financial leverage and risk profile in the future.